Note: Unless noted otherwise, physician, nurse, psychologist, and pharmacist credit will be offered.
Lucia Gagliese, PhD (Moderator); Robert Yezierski, PhD; Joseph Riley
III, PhD; Debra Weiner, MD
1.5 CME/CE
Determining how advancing age affects the biological systems
responsible for the experience of pain represents a major
challenge in pain research. Clinical and preclinical studies
addressing this issue are crucial to gaining a better understanding
of the mechanisms and future treatment strategies
for acute and chronic pain in the elderly.
Raymond Tait, PhD (Moderator); Kenneth Craig, PhD;
Mohammedreza Hojat, PhD
1.5 CME/CE
The role of empathy in the delivery of effective clinical care
has received increased attention in recent years. This is especially
true of empathy for pain, where recent neuroimaging
studies have identified neural substrates related to empathy
for pain in others. This symposium will focus on empathy
among healthcare providers. It will examine empathy from
several perspectives (e.g., how to define and measure it, its role
in pain assessment, its effects on clinical judgments).
Susmita Kashikar-Zuck, PhD (Moderator); Meghan McMarty;
Tonya Palermo, PhD; Christopher Eccleston, PhD; Qian Lu, MD PhD;
Subhadra Evans, PhD
3.0 CME/CE
This session will address findings from basic, translational,
and clinical research on parent-child interactions that determine
children’s pain experience and ability to cope with pain.
There will be an interactive discussion about implications
for the development of effective behavioral therapies using
knowledge gained from laboratory-based research and future
research directions including the combined use of traditional
and nontraditional research methodologies to study social and
cultural factors in pediatric pain.
Robert Kerns, PhD (Moderator); Jodie Trafton, PhD; Bruce Naliboff, PhD;
Bridget Ann Martell, MD MA; Paul Kreis, MD; Kenneth Berkowitz, MD
FCCP; Scott Fishman, MD
3.0 CME/CE
This workshop will review the evidence base for patient-level
and public health concerns related to chronic opioid therapy
and propose strategies for promoting safe and effective use of
opioids. Faculty will also conduct a case-based discussion of
important clinical, ethical, and legal issues relevant to the safe
and effective use of opioids for the management of chronic,
nonmalignant pain.
Robert W. Gereau IV, PhD (Moderator); John N. Wood, PhD DSc;
Sulayman Dib-Hajj, PhD; Michael Jarvis, PhD; Yu-Qing Cao, PhD; Cenk
Ayata, MD; Charlie Taylor, PhD; Terrance Snutch, PhD FRSC
3.0 CME/CE
This workshop focuses on voltage-gated sodium channels
found in nociceptors and their role in pain, as well as voltage-gated
calcium channels in pain transmission and therapy.
Speakers will discuss both inherited pain disorders mediated
by mutations in voltage-gated sodium channels and the
analgesic properties of novel compounds that target these
ion channels. Speakers will also discuss research progress of
calcium channel mutations associated with familial hemiplegic
migraine type 1 as well as compounds that target calcium
channels for chronic pain treatment.
Keela Herr, PhD RN FAAN (Moderator); Perry Fine, MD; Mary Ersek,
PhD RN; Marita Titler, PhD RN FAAN
1.5 CME/CE
Although clinical practice guidelines are available to guide
evidence-based pain management practice in caring for older
adults with pain, evidence suggests those recommendations
are not consistently translated into practice. This symposium
will address current practices for pain management in older
adults in three care settings and discuss translational intervention
strategies to facilitate adoption of evidence-based
practices and their sustainability in acute care.
Steven Stanos, DO (Moderator); Charles Argoff, MD;
Venu Akuthota, MD; Jerome Schofferman, MD
1.5 CME/CE
Transforaminal and interlaminar epidural steroid injections
are a common treatment option for the management of acute
and chronic lumbar radicular pain conditions (i.e., lumbar
herniation, lumbar spinal stenosis). Their efficacy and cost
effectiveness remain controversial. This symposium will
include a review of recently published literature and discussion
of the pros and cons of using epidural injections for lumbar
pain conditions.
Mitchell Max, MD
.5 CME/CE *
John N. Wood, PhD DSc
.5 CME/CE *
Mary Baluss, JD, and Kurt Miller, MD, will present “Producing and Defending a Medico-Legal Report.” A forensic report is the fundamental document produced by an expert—understand what is required and avoid the pitfalls!
Dr. Christopher Austin, director of NIH Chemical Genomics Center, will present “Small Molecule and Transcriptome Tools for Understanding the Genome.” Dr. Colin Fletcher, program director of NIH Knockout Mouse Project, will present “The NIH Knockout Mouse Project (KOMP): A Publicly Available Resource for Translational Science.”
This meeting will be a forum for highlighting SIG accomplishments over the past year and setting goals for 2008-2009. There will be a data blitz during which SIG members can share their latest research findings related to pain and pain management in minority, underserved, and vulnerable populations.
Pain rehabilitation program directors will present information about their programs, including various components, outcome measures, and billing for services.
Todd Vanderah, PhD, and Laura Stone, PhD (Moderators);
Connie Faltyrek, PhD; Narender Gavva, PhD; Gilbert Wong, MD
1.5 CME/CE
Recently, there has been an emphasis within basic science
pain research on the importance of clinical translation of novel
mechanistic targets. One such target on the brink of having a
therapeutic impact is the TRPV1 channel. This family of TRP
channels plays an important role in sensing noxious thermal
stimuli. There have been many reports detailing how such
receptors are activated and desensitized, how other receptors
and intracellular proteins modulate channel function, and
how compounds that block such channels may be the next
therapeutic breakthrough in treating pain patients. However,
the side effects associated with these compounds may deter
their use. A panel of speakers will both defend and refute the
clinical utility of these compounds. Alternative targets within
the family of TRP channels and their therapeutic potential
will also be discussed. This topic is relevant in designing
future clinically translating studies and funding proposals
for basic scientists.
Kick back and relax with your colleagues on Friday, May 9, from 9:30 pm-1 am at Stump’s Supper Club (which is just a short distance from the host hotels) while enjoying the music of the Pain Sensations. Stump’s features Southern hospitality and “retro chic” décor (think Velvet Elvis). A fun-filled evening after a busy meeting day promises Southern food, drinks, live music, and networking. Please indicate whether you will attend by selecting this event in Box F on the registration form.
* Not eligible for pharmacist credit.